COAPT Trial Details for Physicians

The COAPT Trial is the first prospective, randomized, parallel-controlled clinical evaluation of the MitraClip® device for the treatment of clinically significant functional mitral regurgitation in patients not appropriate for mitral valve surgery.

The multicenter study will examine the safety and efficacy of the MitraClip device used in addition to standard care for functional mitral regurgitation and heart failure (device group) compared to treatment with standard care alone (control group). The trial will generate important clinical and economic data to support reimbursement and the development of treatment guidelines.

If you have a patient who meets key eligibility criteria, contact a local trial site. For more information on the trial, visit (keyword “COAPT”).

More Trial Facts »